Life science companies combine to form COVID-19 research database #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

First COVID-19 diagnostic test authorized for home sample collection #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance
22/04/2020
Why COVID-19 Makes Some People Sicker Than Others #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance
22/04/2020

Life science companies combine to form COVID-19 research database #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

A group of major CRO, life science, data analytics, publishing and healthcare companies joined forces to release a pro bono research database to build up and integrate a central hub on the latest data out for COVID-19.

On the technical side, it’s a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets that will be “made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic,” according to the group.

There’s a whole host of companies involved here: Advarra, Aetion, AnalyticsIQ, Arcadia.io, Berkeley Research Group, BHE, Change Healthcare, Datavant, Elsevier, Glooko, Health Care Cost Institute, Healthjump, Helix, Medidata (a Dassault Systèmes company), Mirador Analytics, Munich Re Life US, Office Ally, OMNY, Parexel, Prognos Health, QIAGEN, SAS, Snowflake, Sumitomo Dainippon Pharma, Symphony Health, Veradigm and Verana Health.

Source: www.fiercebiotech.com

Aller au contenu principal